Innate Pharma historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2024-03-19 | 2.185 | 2.220 | 2.175 | 2.215 | 2.215 | 28,628 |
| 2024-03-18 | 2.200 | 2.220 | 2.165 | 2.190 | 2.190 | 62,181 |
| 2024-03-15 | 2.220 | 2.225 | 2.155 | 2.155 | 2.155 | 63,407 |
| 2024-03-14 | 2.240 | 2.250 | 2.215 | 2.215 | 2.215 | 18,039 |
| 2024-03-13 | 2.205 | 2.245 | 2.200 | 2.240 | 2.240 | 26,141 |
| 2024-03-12 | 2.230 | 2.250 | 2.180 | 2.240 | 2.240 | 51,360 |
| 2024-03-11 | 2.290 | 2.345 | 2.225 | 2.230 | 2.230 | 73,303 |
| 2024-03-08 | 2.310 | 2.395 | 2.290 | 2.290 | 2.290 | 32,046 |
| 2024-03-07 | 2.310 | 2.375 | 2.310 | 2.345 | 2.345 | 47,021 |
| 2024-03-06 | 2.280 | 2.380 | 2.250 | 2.300 | 2.300 | 208,070 |
| 2024-03-05 | 2.235 | 2.240 | 2.200 | 2.200 | 2.200 | 100,530 |
| 2024-03-04 | 2.245 | 2.315 | 2.200 | 2.205 | 2.205 | 44,124 |
| 2024-03-01 | 2.195 | 2.280 | 2.190 | 2.275 | 2.275 | 50,898 |
| 2024-02-29 | 2.400 | 2.400 | 2.120 | 2.185 | 2.185 | 324,174 |
| 2024-02-28 | 2.400 | 2.440 | 2.330 | 2.360 | 2.360 | 60,657 |
| 2024-02-27 | 2.400 | 2.400 | 2.335 | 2.355 | 2.355 | 41,897 |
| 2024-02-26 | 2.400 | 2.430 | 2.360 | 2.400 | 2.400 | 49,946 |
| 2024-02-23 | 2.325 | 2.440 | 2.325 | 2.400 | 2.400 | 105,470 |
| 2024-02-22 | 2.285 | 2.360 | 2.245 | 2.350 | 2.350 | 83,917 |
| 2024-02-21 | 2.265 | 2.280 | 2.240 | 2.255 | 2.255 | 23,209 |
| 2024-02-20 | 2.300 | 2.300 | 2.260 | 2.290 | 2.290 | 22,893 |
| 2024-02-19 | 2.285 | 2.305 | 2.270 | 2.285 | 2.285 | 20,811 |
| 2024-02-16 | 2.315 | 2.325 | 2.280 | 2.305 | 2.305 | 46,181 |
| 2024-02-15 | 2.260 | 2.325 | 2.215 | 2.310 | 2.310 | 91,725 |
| 2024-02-14 | 2.260 | 2.260 | 2.240 | 2.250 | 2.250 | 21,380 |
| 2024-02-13 | 2.270 | 2.300 | 2.260 | 2.260 | 2.260 | 36,138 |
| 2024-02-12 | 2.240 | 2.300 | 2.230 | 2.265 | 2.265 | 52,440 |
| 2024-02-09 | 2.250 | 2.275 | 2.230 | 2.240 | 2.240 | 61,604 |
| 2024-02-08 | 2.300 | 2.320 | 2.255 | 2.255 | 2.255 | 47,155 |
| 2024-02-07 | 2.350 | 2.370 | 2.280 | 2.290 | 2.290 | 96,149 |
| 2024-02-06 | 2.350 | 2.385 | 2.320 | 2.380 | 2.380 | 113,510 |
| 2024-02-05 | 2.345 | 2.395 | 2.330 | 2.350 | 2.350 | 111,948 |
| 2024-02-02 | 2.385 | 2.420 | 2.320 | 2.350 | 2.350 | 81,213 |
| 2024-02-01 | 2.500 | 2.500 | 2.385 | 2.385 | 2.385 | 70,582 |
| 2024-01-31 | 2.515 | 2.540 | 2.465 | 2.470 | 2.470 | 45,061 |
| 2024-01-30 | 2.585 | 2.590 | 2.500 | 2.550 | 2.550 | 55,470 |
| 2024-01-29 | 2.520 | 2.560 | 2.500 | 2.550 | 2.550 | 23,153 |
| 2024-01-26 | 2.580 | 2.625 | 2.510 | 2.515 | 2.515 | 146,062 |
| 2024-01-25 | 2.580 | 2.595 | 2.540 | 2.560 | 2.560 | 51,952 |
| 2024-01-24 | 2.520 | 2.585 | 2.490 | 2.520 | 2.520 | 85,399 |
| 2024-01-23 | 2.480 | 2.520 | 2.450 | 2.510 | 2.510 | 26,194 |
| 2024-01-22 | 2.450 | 2.500 | 2.450 | 2.455 | 2.455 | 42,236 |
| 2024-01-19 | 2.450 | 2.475 | 2.450 | 2.450 | 2.450 | 54,487 |
| 2024-01-18 | 2.490 | 2.495 | 2.450 | 2.450 | 2.450 | 54,175 |
| 2024-01-17 | 2.530 | 2.530 | 2.445 | 2.475 | 2.475 | 81,760 |
| 2024-01-16 | 2.475 | 2.530 | 2.390 | 2.500 | 2.500 | 106,382 |
| 2024-01-15 | 2.510 | 2.560 | 2.475 | 2.490 | 2.490 | 62,312 |
| 2024-01-12 | 2.510 | 2.560 | 2.510 | 2.550 | 2.550 | 69,830 |
| 2024-01-11 | 2.505 | 2.555 | 2.500 | 2.545 | 2.545 | 91,543 |
| 2024-01-10 | 2.580 | 2.590 | 2.465 | 2.505 | 2.505 | 130,711 |
| 2024-01-09 | 2.670 | 2.670 | 2.565 | 2.580 | 2.580 | 60,185 |
| 2024-01-08 | 2.680 | 2.690 | 2.595 | 2.610 | 2.610 | 136,312 |
| 2024-01-05 | 2.745 | 2.745 | 2.635 | 2.695 | 2.695 | 171,090 |
| 2024-01-04 | 2.640 | 2.800 | 2.565 | 2.760 | 2.760 | 531,797 |
| 2024-01-03 | 2.640 | 2.640 | 2.500 | 2.520 | 2.520 | 137,847 |
| 2024-01-02 | 2.630 | 2.690 | 2.575 | 2.640 | 2.640 | 201,467 |
| 2023-12-29 | 2.565 | 2.645 | 2.540 | 2.620 | 2.620 | 129,114 |
| 2023-12-28 | 2.560 | 2.570 | 2.530 | 2.560 | 2.560 | 88,274 |
| 2023-12-27 | 2.520 | 2.600 | 2.500 | 2.540 | 2.540 | 183,705 |
| 2023-12-22 | 2.555 | 2.575 | 2.455 | 2.475 | 2.475 | 134,668 |
Stock splits
No stock splits on record.
Dividends
No dividends on record.
Open, high, low and close are as traded (EUR). Adjusted close accounts for splits and dividends. Educational only, not financial advice.